Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-25 @ 9:11 PM
Study NCT ID:
NCT00875056
Status:
COMPLETED
Last Update Posted:
2020-10-29
First Post:
2009-04-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04-15
Start Date Type:
ACTUAL
Primary Completion Date:
2011-09-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-02
First Submit QC Date:
None
Study First Post Date:
2009-04-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-10-06
Results First Submit QC Date:
None
Results First Post Date:
2020-10-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-06
Last Update Post Date:
2020-10-29
Last Update Post Date Type:
ACTUAL